These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25392130)

  • 1. Aβ anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administration.
    Loeffler DA; Klaver AC; Coffey MP
    Autoimmunity; 2015 Jun; 48(4):196-200. PubMed ID: 25392130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies.
    Klaver AC; Coffey MP; Smith LM; Loeffler DA
    Immunol Lett; 2013; 154(1-2):7-11. PubMed ID: 23928186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of antibodies against β-amyloid 40/42 monomer and oligomers in Chinese intravenous immunoglobulins.
    Ye S; Zeng R; Jiang P; Hou M; Liu F; Wang Z; Du X; Yuan J; Chen Y; Cao H; Ma L; Li C
    J Pharm Biomed Anal; 2017 May; 138():277-282. PubMed ID: 28231531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations.
    Klaver AC; Finke JM; Digambaranath J; Balasubramaniam M; Loeffler DA
    Int Immunopharmacol; 2010 Jan; 10(1):115-9. PubMed ID: 19840873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin products.
    Loeffler DA; Klaver AC; Coffey MP
    Int Immunopharmacol; 2015 Oct; 28(2):1108-12. PubMed ID: 26330100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein.
    Smith LM; Coffey MP; Klaver AC; Loeffler DA
    Int Immunopharmacol; 2013 Aug; 16(4):424-8. PubMed ID: 23669333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural human antibodies to amyloid beta peptide.
    Szabo P; Relkin N; Weksler ME
    Autoimmun Rev; 2008 Jun; 7(6):415-20. PubMed ID: 18558354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
    Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
    Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.
    Cattepoel S; Gaida A; Kropf A; Nolte MW; Bolli R; Miescher SM
    PLoS One; 2016; 11(8):e0161826. PubMed ID: 27561008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins for Alzheimer's disease.
    Puli L; Tanila H; Relkin N
    Curr Alzheimer Res; 2014; 11(7):626-36. PubMed ID: 25115546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding.
    Klaver AC; Patrias LM; Coffey MP; Finke JM; Loeffler DA
    J Neurosci Methods; 2010 Mar; 187(2):263-9. PubMed ID: 20097229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.
    Kwon H; Crisostomo AC; Smalls HM; Finke JM
    PLoS One; 2015; 10(3):e0120420. PubMed ID: 25826319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy-chain complementarity-determining regions determine conformation selectivity of anti-aβ antibodies.
    Sehlin D; Hedlund M; Lord A; Englund H; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
    Neurodegener Dis; 2011; 8(3):117-23. PubMed ID: 20714111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
    Relkin NR; Szabo P; Adamiak B; Burgut T; Monthe C; Lent RW; Younkin S; Younkin L; Schiff R; Weksler ME
    Neurobiol Aging; 2009 Nov; 30(11):1728-36. PubMed ID: 18294736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    Kasai T; Kondo M; Ishii R; Tanaka A; Ataka S; Shimada H; Tomiyama T; Mori H; Taylor M; Allsop D; Nakagawa M; Mizuno T; Tokuda T
    PLoS One; 2017; 12(4):e0174630. PubMed ID: 28394917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of intravenous immunoglobulin products to tau peptide fragments.
    Smith LM; Coffey MP; Loeffler DA
    Int Immunopharmacol; 2014 Aug; 21(2):279-82. PubMed ID: 24859060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial injection of Gammagard, a human IVIg, modulates the inflammatory response of the brain and lowers Aβ in APP/PS1 mice along a different time course than anti-Aβ antibodies.
    Sudduth TL; Greenstein A; Wilcock DM
    J Neurosci; 2013 Jun; 33(23):9684-92. PubMed ID: 23739965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?
    Loeffler DA
    J Neuroinflammation; 2014 Dec; 11():198. PubMed ID: 25476011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.